US 9,890,141

Application 15/144,892 · Granted Feb 13, 2018

Crystalline pharmaceutical and methods of preparation and use thereof

Estimated expiration

October 21, 2030

3y 335d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
Earliest effective filing
Oct 21, 2010
+ 20 years
Oct 21, 2030
PTA +0d
Oct 21, 2030
TD cap (US 9,353,088)
Oct 21, 2030
Final
Oct 21, 2030

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).

Calculation details

Base term

Filing date
May 3, 2016
Earliest effective filing
October 21, 2010
Issue date
February 13, 2018
PTA
0 days
Base expiry (before PTA)
October 21, 2030

October 21, 2010 + 20 years = October 21, 2030

  • Continuation of application 14/556,715, filed Dec 1, 2014, issued as US 9,353,088
  • Continuation of application 13/713,238, filed Dec 13, 2012, issued as US 8,927,574
  • Continuation of application 12/909,241, filed Oct 21, 2010, issued as US 8,378,105
  • Continuation of application 12/909,241, filed Oct 21, 2010, issued as US 8,378,105
  • Continuation of application 13/713,238, filed Dec 13, 2012, issued as US 8,927,574
  • Continuation of application 12/909,241, filed Oct 21, 2010, issued as US 8,378,105
  • PRO61/253,828 — Provisional — not used for base term
  • PRO61/253,828 — Provisional — not used for base term
  • PRO61/253,828 — Provisional — not used for base term
  • PRO61/253,828 — Provisional — not used for base term

Terminal disclaimers

TD approved1 approved, 1 filed

TD caps expiration to October 21, 2030 (earliest expiring referenced patent: US 9,353,088)

  • US 8,378,105· Application 12/909,241Capping patent

    Crystalline pharmaceutical and methods of preparation and use thereof

    Filing date
    Oct 21, 2010
    Earliest effective filing
    Oct 21, 2010
    Issue date
    Feb 19, 2013
    PTA
    +139 days
    Calculated expiration
    Mar 9, 2031

    Oct 21, 2010 + 20y + 139d PTA = Mar 9, 2031

  • US 9,353,088· Application 14/556,715Capping patent

    Crystalline pharmaceutical and methods of preparation and use thereof

    Filing date
    Dec 1, 2014
    Earliest effective filing
    Oct 21, 2010
    Issue date
    May 31, 2016
    PTA
    0 days
    Calculated expiration
    Oct 21, 2030

    Continuation of 13/713,238, filed Dec 13, 2012, issued as US 8,927,574

    Continuation of 12/909,241, filed Oct 21, 2010, issued as US 8,378,105

    Continuation of 12/909,241, filed Oct 21, 2010, issued as US 8,378,105

    Oct 21, 2010 + 20y = Oct 21, 2030

  • US 9,890,141· Application 15/144,892(from application 15/144,892)

    Crystalline pharmaceutical and methods of preparation and use thereof

    Filing date
    May 3, 2016
    Earliest effective filing
    Oct 21, 2010
    Issue date
    Feb 13, 2018
    PTA
    0 days
    Calculated expiration
    Oct 21, 2030

    Continuation of 14/556,715, filed Dec 1, 2014, issued as US 9,353,088

    Continuation of 13/713,238, filed Dec 13, 2012, issued as US 8,927,574

    Continuation of 12/909,241, filed Oct 21, 2010, issued as US 8,378,105

    Continuation of 12/909,241, filed Oct 21, 2010, issued as US 8,378,105

    Continuation of 13/713,238, filed Dec 13, 2012, issued as US 8,927,574

    Continuation of 12/909,241, filed Oct 21, 2010, issued as US 8,378,105

    Oct 21, 2010 + 20y = Oct 21, 2030

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 15/144,892 · US 9,890,141

PatentReply compiles the prosecution history behind US 9,890,141: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US9890141

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.